<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38193771</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1534-7796</ISSN><JournalIssue CitedMedium="Internet"><Volume>86</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>Psychosomatic medicine</Title><ISOAbbreviation>Psychosom Med</ISOAbbreviation></Journal><ArticleTitle>Preexisting Psychiatric Conditions as Risk Factors for Diagnosed Long COVID-19 Syndrome Within Aggregated Electronic Health Record Data.</ArticleTitle><Pagination><StartPage>132</StartPage><EndPage>136</EndPage><MedlinePgn>132-136</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/PSY.0000000000001280</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aimed to investigate the frequency of long COVID diagnosis among patients infected with severe acute respiratory syndrome coronavirus 2 with preexisting psychiatric conditions versus those without preexisting psychiatric conditions.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The TriNetX Analytics platform, an aggregated electronic health record research network containing the deidentified electronic health record data of more than 90 million patients, was queried for patients who were diagnosed with COVID-19 infection based on International Classifications of Disease, Tenth Revision codes. Patients were stratified based on their preexisting psychiatric conditions, and new diagnoses of long COVID were recorded and reported as the primary outcome.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 1,180,948 patients previously diagnosed with COVID-19, 17,990 patients (1.52%) were diagnosed with long COVID based on the newly implemented International Classifications of Disease, Tenth Revision code "U09: post-COVID-19 condition." After propensity score matching, patients with any preexisting psychiatric diagnosis had a 1.52 (95% confidence interval [CI] = 1.47-1.58) times greater prevalence of diagnosed long COVID within 180 days of infection than patients without preexisting psychiatric diagnoses. Patients with diagnosed anxiety disorders (relative risk [RR] = 1.64; 95% CI = 1.57-1.71), mood disorders (RR = 1.65; 95% CI = 1.57-1.72), bipolar disorder (RR = 1.37; 95% CI = 1.21-1.54), major depressive disorder (RR = 1.69; 95% CI = 1.56-1.83), psychotic disorders (RR = 1.23; 95% CI = 1.06-1.44), and substance use disorders (RR = 1.28; 95% CI = 1.22-1.36) had higher risks for long COVID diagnoses when compared with patients without preexisting psychiatric illness at the time of diagnosis.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Multiple preexisting psychiatric diagnoses are associated with an increased risk of being diagnosed with long COVID after COVID-19 infection.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 by the American Psychosomatic Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bobak</LastName><ForeName>Lukas</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-4000-6880</Identifier><AffiliationInfo><Affiliation>From the Case Western Reserve University School of Medicine (Bobak, Dorney, Kaelber); Department of Psychiatry and Psychology (Kovacevich, Barnett), Center for Behavioral Health, Neurological Institute, Cleveland Clinic; Cleveland Clinic Lerner College of Medicine at Case Western Reserve University (Barnett), EC-10 Cleveland Clinic, Cleveland, Ohio; Departments of Internal Medicine (Kaelber), Pediatrics, and Population and Quantitative Health Sciences, Case Western Reserve University; and The Center for Clinical Informatics Research and Education (Kaelber), The MetroHealth System, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dorney</LastName><ForeName>Ian</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-2520-0557</Identifier></Author><Author ValidYN="Y"><LastName>Kovacevich</LastName><ForeName>Alexsandra</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4196-467</Identifier></Author><Author ValidYN="Y"><LastName>Barnett</LastName><ForeName>Brian</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-8963-5701</Identifier></Author><Author ValidYN="Y"><LastName>Kaelber</LastName><ForeName>David C</ForeName><Initials>DC</Initials><Identifier Source="ORCID">0000-0001-7855-9515</Identifier></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR002548</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 TR004528</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Psychosom Med</MedlineTA><NlmUniqueID>0376505</NlmUniqueID><ISSNLinking>0033-3174</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003865" MajorTopicYN="Y">Depressive Disorder, Major</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001523" MajorTopicYN="Y">Mental Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Conflicts of Interest and Source of Funding. Brian Barnett reports a relationship with CB Therapeutics that includes: board membership and equity or stocks. Brian Barnett reports a relationship with COMPASS Pathways Plc that includes: board membership. Brian Barnett reports a relationship with Mind Medicine Inc. that includes: funding grants. Brian Barnett reports a relationship with EBSCO Industries Inc that includes: consulting or advisory. Brian Barnett reports a relationship with Cerebral that includes: consulting or advisory. Lukas Bobak, Ian Dorney, Alexsandra Kovacevich, and David C. Kaelber report no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>9</Day><Hour>13</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>9</Day><Hour>9</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38193771</ArticleId><ArticleId IdType="mid">NIHMS1955454</ArticleId><ArticleId IdType="pmc">PMC11001529</ArticleId><ArticleId IdType="doi">10.1097/PSY.0000000000001280</ArticleId><ArticleId IdType="pii">00006842-990000000-00187</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Centers for Disease Control and Prevention. (n.d.). Post-covid conditions: Information for healthcare providers. Centers for Disease Control and Prevention. Retrieved April 15, 2023, from https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html</Citation></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021. Jul 26;374:n1648. doi: 10.1136/bmj.n1648. Erratum in: BMJ. 2021 Aug 3;374:n1944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022. Aug;28(8):1706&#x2013;1714. doi: 10.1038/s41591-022-01909-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM; Lifelines Corona Research Initiative. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022. Aug 6;400(10350):452&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open. 2021;4(5):e2111417. doi:10.1001/jamanetworkopen.2021.11417)</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 23, 210&#x2013;216 (2022)</Citation><ArticleIdList><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z et al. Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin. Infect. Dis</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD &amp; VanElzakker MB Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front. Microbiol. 12, 698169 (2021)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Chudzik M, Babicki M, Kapusta J, Ka&#x142;uzi&#x144;ska-Ko&#x142;at &#x17b;, Ko&#x142;at D, Jankowski P, et al. Long-COVID Clinical Features and Risk Factors: A Retrospective Analysis of Patients from the STOP-COVID Registry of the PoLoCOV Study. Viruses. 2022. Aug 11;14(8):1755. doi: 10.3390/v14081755.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14081755</ArticleId><ArticleId IdType="pmc">PMC9415629</ArticleId><ArticleId IdType="pubmed">36016376</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen S, Doyle WJ, &amp; Skoner DP (1999). Psychological stress, cytokine production, and severity of upper respiratory illness. Psychosomatic medicine, 61(2), 175&#x2013;180.</Citation><ArticleIdList><ArticleId IdType="pubmed">10204970</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Quan L, Chavarro JE, et al. Associations of Depression, Anxiety, Worry, Perceived Stress, and Loneliness Prior to Infection With Risk of Post&#x2013;COVID-19 Conditions. JAMA Psychiatry. 2022;79(11):1081&#x2013;1091. doi:10.1001/jamapsychiatry.2022.2640</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2022.2640</ArticleId><ArticleId IdType="pmc">PMC9453634</ArticleId><ArticleId IdType="pubmed">36069885</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#x103;unescu RL, Miclu Ia IV, Veri&#x15f;ezan OR, Crecan-Suciu BD. Acute and long&#x2011;term psychiatric symptoms associated with COVID&#x2011;19 (Review). Biomed Rep. 2022. Nov 17;18(1):4. doi: 10.3892/br.2022.1586.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/br.2022.1586</ArticleId><ArticleId IdType="pmc">PMC9756282</ArticleId><ArticleId IdType="pubmed">36544852</ArticleId></ArticleIdList></Reference><Reference><Citation>Schou TM, Joca S, Wegener G, Bay-Richter C. Psychiatric and neuropsychiatric sequelae of COVID-19 - A systematic review. Brain Behav Immun. 2021. Oct;97:328&#x2013;348. doi: 10.1016/j.bbi.2021.07.018. Epub 2021 Jul 30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.07.018</ArticleId><ArticleId IdType="pmc">PMC8363196</ArticleId><ArticleId IdType="pubmed">34339806</ArticleId></ArticleIdList></Reference><Reference><Citation>Z&#xfc;rcher SJ, Banzer C, Adamus C, Lehmann AI, Richter D, Kerksieck P. Post-viral mental health sequelae in infected persons associated with COVID-19 and previous epidemics and pandemics: Systematic review and meta-analysis of prevalence estimates. J Infect Public Health. 2022. May;15(5):599&#x2013;608. doi: 10.1016/j.jiph.2022.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2022.04.005</ArticleId><ArticleId IdType="pmc">PMC9020842</ArticleId><ArticleId IdType="pubmed">35490117</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Luciano S, Geddes JR, &amp; Harrison PJ (2021). Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. The Lancet Psychiatry, 8(2), 130&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I, et al. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav Immun. 2020. Oct;89:594&#x2013;600. doi: 10.1016/j.bbi.2020.07.037. Epub 2020 Jul 30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.07.037</ArticleId><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62&#x2008;354 COVID-19 cases in the USA. Lancet Psychiatry. 2021. Feb;8(2):130&#x2013;140. doi: 10.1016/S2215-0366(20)30462-4. Epub 2020 Nov 9. Erratum in: Lancet Psychiatry. 2021 Jan;8(1):e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30462-4</ArticleId><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>Kataoka M, Hazumi M, Usuda K, Okazaki E, Nishi D. Association of preexisting psychiatric disorders with post-COVID-19 prevalence: a cross-sectional study. Sci Rep. 2023. Jan 7;13(1):346. doi: 10.1038/s41598-023-27405-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-27405-w</ArticleId><ArticleId IdType="pmc">PMC9823253</ArticleId><ArticleId IdType="pubmed">36611076</ArticleId></ArticleIdList></Reference><Reference><Citation>New ICD-10-CM code for the in March 2020 the novel coronavirus disease &#x2026; (n.d.). Retrieved April 15, 2023, from https://www.cdc.gov/nchs/data/icd/Announcement-New-ICD-code-for-coronavirus-19-508.pdf</Citation></Reference><Reference><Citation>Nadalin S, Jakovac H, Peitl V, Karlovi&#x107; D, Bureti&#x107;-Tomljanovi&#x107; A. Dysregulated inflammation may predispose patients with serious mental illnesses to severe COVID&#x2011;19 (Review). Mol Med Rep. 2021. Aug;24(2):611. doi: 10.3892/mmr.2021.12250.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2021.12250</ArticleId><ArticleId IdType="pmc">PMC8258463</ArticleId><ArticleId IdType="pubmed">34184073</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan N, Chen Y, Xia Y, Dai J, Liu C. Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses. Transl Psychiatry. 2019. Sep 18;9(1):233. doi: 10.1038/s41398-019-0570-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-019-0570-y</ArticleId><ArticleId IdType="pmc">PMC6751188</ArticleId><ArticleId IdType="pubmed">31534116</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouayed J, Rammal H, Soulimani R. Oxidative stress and anxiety: relationship and cellular pathways. Oxid Med Cell Longev. 2009. Apr-Jun;2(2):63&#x2013;7. doi: 10.4161/oxim.2.2.7944.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/oxim.2.2.7944</ArticleId><ArticleId IdType="pmc">PMC2763246</ArticleId><ArticleId IdType="pubmed">20357926</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Feltz-Cornelis CM, Ten Have M, Penninx BW, Beekman AT, Smit JH, De Graaf R. Presence of comorbid somatic disorders among patients referred to mental health care in the Netherlands. Psychiatr Serv. 2010. Nov;61(11):1119&#x2013;25. doi: 10.1176/ps.2010.61.11.1119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/ps.2010.61.11.1119</ArticleId><ArticleId IdType="pubmed">21041351</ArticleId></ArticleIdList></Reference><Reference><Citation>McGrath LJ, Scott AM, Surinach A, Chambers R, Benigno M, Malhotra D. Use of the Postacute Sequelae of COVID-19 Diagnosis Code in Routine Clinical Practice in the US. JAMA Netw Open. 2022;5(10):e2235089. doi:10.1001/jamanetworkopen.2022.35089</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.35089</ArticleId><ArticleId IdType="pmc">PMC9539719</ArticleId><ArticleId IdType="pubmed">36201207</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis KA, Sudlow CL, Hotopf M. Can mental health diagnoses in administrative data be used for research? A systematic review of the accuracy of routinely collected diagnoses. BMC Psychiatry. 2016. Jul 26;16:263. doi: 10.1186/s12888-016-0963-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12888-016-0963-x</ArticleId><ArticleId IdType="pmc">PMC4960739</ArticleId><ArticleId IdType="pubmed">27455845</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>